Lab Tests Normal Values and Units of Measure the rsults

List Of Lab Tests Normal Values with Conventional Units, SI Units. Each commercial laboratory has its own set of normal values, called Normal Range or Reference Range on your lab report. These values depend on the equipment or method used. Compare your results to the range shown on your lab report. Results that are out of range may not represent a problem.

Reference values vary based on several factors, including the specific laboratory that supplies them. A patient’s blood test values should be interpreted based on the reference value of the laboratory in which the test was done; the laboratory typically provides these values with the test result. Representative values are listed in alphabetical order in the following table.

Normal Values Source 1:

Test name	With Conventional Units	With IS Units
+Antitrypsin, Alpha-1 (AAT)	83–199 mg/dL	15.3–36.6 mcmol/L
11-Deoxycortisol (DOC): After metyrapone	> 7 mcg/dL	> 203 nmol/L
11-Deoxycortisol (DOC): Basal	< 5 mcg/dL	< 145 nmol/L
5′-Nucleotidase (5’NT)	4–11.5 U/L	—
Acetoacetate	< 3 mg/L	< 0.3 mmol/L
Acetylcholinesterase (AChE), red blood cells	26.7–49.2 U/g Hb	1.72–3.17 x 106 U/mol Hb
Acid phosphatase (adults)	0.5–5 U/L	8–83 nkat/L
Activated partial thromboplastin time (aPTT)	30–40 seconds	—
Adrenocorticotropic hormone (ACTH)	9–52 pg/mL (morning draw)	2–11 pmol/L (morning draw)
Albumin	3.5–5.4 g/dL	35–54 g/L
Aldosterone: Standing	7–20 ng/dL	194–554 pmol/L
Aldosterone: Supine	2–5 ng/dL	55–138 pmol/L
Alkaline phosphatase (ALP)	36–150 U/L	0.5–2.5 mckat/L
Alpha fetoprotein (AFP)	< 20 ng/mL	< 20 mcg/L
Alpha-1 antitrypsin (AAT)	100–273 mg/dL	18–50 mcmol/L
Alpha-1 globulins	0.2–0.4 g/dL	2–4 g/L
Alpha-2 globulins	0.5–0.9 g/dL	5–9 g/L
Aminolevulinic acid, Delta (ALA)	15–23 mcg/L	1.14–1.75 mcmol/L
Aminotransferase, alanine (ALT)	< 35 U/L	< 0.58 mckat/L
Aminotransferase, aspartate (AST)	< 35 U/L	< 0.58 mckat/L
Ammonia	40–80 mcg/dL	23–47 mcmol/L
Amylase	< 110 U/L	< 1.8 mckat/L
Antibodies to extractable nuclear antigen (AENA)	< 20.0 units/mL	—
Anti–cyclic citrullinated peptide (anti-CCP) antibodies	≤ 20 units/mL	—
Antidiuretic hormone (ADH; arginine vasopressin)	< 1.7 pg/mL	< 1.57 pmol/L
Anti–double-stranded DNA (dsDNA) antibodies, IgG	< 25 IU	—
Antimitochondrial M2 antibodies	< 0.1 units	—
Antineutrophil cytoplasmic antibodies (cANCA)	Negative	—
Antinuclear antibodies (ANA)	≤ 1.0 units	—
Anti–smooth muscle antibodies (ASMA) titer	≤ 1:80	—
Antistreptolysin O titer	< 150 units	—
Antithyroid microsomal antibody titer	< 1:100	—
Apolipoproteins: A-I, females	98–210 mg/dL	0.98–2.1 g/L
Apolipoproteins: A-I, males	88–180 mg/dL	0.88–1.8 g/L
Apolipoproteins: B-100, females	44–148 mg/dL	0.44–1.48 g/L
Apolipoproteins: B-100, males	55–151 mg/dL	0.55–1.51 g/L
Band neutrophils	0–1.2 x 103 cells/mcL	0–1.2 x 109 cells/L
Basophils	0–0.22 x 103 cells/mcL	0–0.22 x 109 cells/L
Beta globulins	0.6–1.1 g/dL	6–11 g/L
Beta-2 microglobulin	0.7–1.8 mcg/mL	0.7–1.8 mg/L
Bicarbonate	23–28 mEq/L	23–28 mmol/L
Bilirubin: Direct	0–0.3 mg/dL	0–5.1 mcmol/L
Bilirubin: Total	0.3–1.2 mg/dL	5.1–20.5 mcmol/L
Brain (B-type) natriuretic peptide (BNP)	< 100 pg/mL	< 100 ng/L
C3	90–180 mg/dL	0.9–1.8 g/L
C4	10–40 mg/dL	0.10–0.40 g/L
CA 125	< 35 U/mL	< 35 kU/L
CA 15-3	< 30 U/mL	< 30 kU/L
Calcitonin, age ≥ 16 years: Females	< 8 pg/mL	< 8ng/L
Calcitonin, age ≥ 16 years: Males	< 16 pg/mL	< 16 ng/L
Calcium	9–10.5 mg/dL	2.2–2.6 mmol/L
Carbon dioxide (CO2) content	23–28 mEq/L	23–28 mmol/L
Carbon dioxide partial pressure (PCO2)	Arterial: 35–45 mm Hg	Arterial: 4.7–6.0 kPa
Carbon dioxide partial pressure (PCO2)	Venous: 38–50 mm Hg	Venous: 5.1–6.7 kPa
Carboxyhemoglobin	0.5–5%	—
Carcinoembryonic antigen (CEA)	< 3 ng/mL	< 3 mcg/L
Carcinoembryonic antigen (CEA)	Patients who smoke: < 5 ng/mL	Patients who smoke: < 5 mcg/L
Carotene	75–300 mcg/dL	1.4–5.6 mcmol/L
CD4:CD8 ratio	1.0–4.0	—
CD4+ T-cell count	640–1175/mcL	0.64–1.18 x 109/L
CD8+ T-cell count	335–875/mcL	0.34–0.88 x 109/L
Ceruloplasmin	14–40 mg/dL	0.93–2.65 mcmol/L
Chloride	98–106 mEq/L	98–106 mmol/L
Copper	70–155 mcg/L	11–24.3 mcmol/L
Cortisol: 1 hour after cosyntropin	> 18 mcg/dL and usually ≥ 8 mcg/dL above baseline	> 498 nmol/L and usually ≥ 221 nmol/L above baseline
Cortisol: After overnight suppression test	< 5 mcg/dL	< 138 nmol/L
Cortisol: At 5 PM	3–13 mcg/dL	83–359 nmol/L
Cortisol: At 8 AM	8–20 mcg/dL	251–552 nmol/L
C-peptide	0.9–4.3 ng/mL	297–1419 pmol/L
C-reactive protein (CRP)	< 0.8 mg/dL	< 8.0 mg/L
C-reactive protein, highly sensitive (hsCRP)	< 0.2 mg/dL	< 2.0 mg/L
Creatine kinase (CK)	30–170 U/L	0.5–2.83 mckat/L
Creatinine: Female	0.5–1.0 mg/dL	45–90 mcmol/L
Creatinine: Male	0.7–1.2 mg/dL	60–110 mcmol/L
D-dimer	≤ 500 ng/mL FEU (Fibrinogen Equivalent Units)	< 3 nmol/L FEU
Dehydroepiandrosterone sulfate (DHEA-S): Females	0.6–3.3 mg/mL	1.6–8.9 mcmol/L
Dehydroepiandrosterone sulfate (DHEA-S): Males	1.3–5.5 mg/mL	3.5–14.9 mcmol/L
Delta-aminolevulinic acid (ALA)	15–23 mcg/L	1.14–1.75 mcmol/L
D-Xylose level 2 hours after ingestion of 25 g of D-xylose	> 20 mg/dL	> 1.3 nmol/L
Eosinophils	0–0.55 x 103 cells/mcL	0–0.55 x 109 cells/L
Epinephrine, supine	< 75 ng/L	< 410 pmol/L
Erythropoietin	2.6–18.5 mIU/mL	2.6–18.5 IU/L
ESR: Females	0–20 mm/hour	0–20 mm/hour
ESR: Males	0–15 mm/hour	0–20 mm/hour
Estradiol, females: Day 1–10 of menstrual cycle	14–27 pg/mL	50–100 pmol/L
Estradiol, females: Day 11–20 of menstrual cycle	14–54 pg/mL	50–200 pmol/L
Estradiol, females: Day 21–30 of menstrual cycle	19–40 pg/mL	70–150 pmol/L
Estradiol, males	10–30 pg/mL	37–110 pmol/L
Factor I	150–300 mg/dL	1.5–3.5 g/L
Factor II	60–150% of normal	—
Factor IX	60–150% of normal	—
Factor V	60–150% of normal	—
Factor VII	60–150% of normal	—
Factor VIII	60–150% of normal	—
Factor X	60–150% of normal	—
Factor XI	60–150% of normal	—
Factor XII	60–150% of normal	—
Ferritin: Females	30–200 ng/mL	30–200 mcg/L
Ferritin: Males	30–300 ng/mL	30–300 mcg/L
Fetoprotein, Alpha (AFP)	< 8.4 ng/mL	< 8.4 mcg/L
Fibrinogen	150–350 mg/dL	1.5–3.5 g/L
Folate (folic acid): Red blood cells	160–855 ng/mL	362–1937 nmol/L
Folate (folic acid): Serum	2.5–20 ng/mL	5.7–45.3 nmol/L
Follicle-stimulating hormone (FSH), adult males	5–15 mU/mL	5–15 U/L
Fructosamine (glycated protein)	200–285 mcmol/L	200-285 mcmol/L
FSH: Females: Follicular or luteal phase	5–20 mU/mL	5–20 U/L
FSH: Females: Midcycle peak	30–50 mU/mL	30–50 U/L
FSH: Females: Postmenopausal	> 35 mU/mL	> 35 U/L
Gamma globulins	0.7–1.7 g/dL	7–17 g/L
Gastrin	0–180 pg/mL	0–180 ng/L
GGT: Adult Females:	5–36 U/L	0.09–0.61 mckat/L
GGT: Adult Males:	8–61 U/L	0.14–1.03 mckat/L
Globulins:	2.5–3.5 g/dL	25–35 g/L
Glucose: 2-hour postprandial	< 140 mg/dL	< 7.8 mmol/L
Glucose: Fasting	70–105 mg/dL	3.9–5.8 mmol/L
Glucose-6-phosphate dehydrogenase (G6PD)	5–15 U/g Hb	0.32–0.97 mU/ mol Hb
Growth hormone: After oral glucose	< 2 ng/mL	< 2 mcg/L
Growth hormone: In response to provocative stimuli	> 7 ng/mL	> 7 mcg/L
Haptoglobin	30–200 mg/dL	0.3–2 g/L
Hematocrit: Females	36–47%	—
Hematocrit: Males	41–51%	—
Hemoglobin A1C	4.7–8.5%	—
Hemoglobin electrophoresis, adults: Hb A1	95–98%	—
Hemoglobin electrophoresis, adults: Hb A2	2–3%	—
Hemoglobin electrophoresis, adults: Hb C	0%	—
Hemoglobin electrophoresis, adults: Hb F	0.8–2.0%	—
Hemoglobin electrophoresis, adults: Hb S	0%	—
Hemoglobin electrophoresis, Hb F in children: > 6 months	1–2%	—
Hemoglobin electrophoresis, Hb F in children: 1–6 months	8%	—
Hemoglobin electrophoresis, Hb F in children: Neonate	50–80%	—
Hemoglobin: Females	12–16 g/dL	120–160 g/L
Hemoglobin: Males	14–17 g/dL	140–170 g/L
High-density lipoprotein (HDL-C)	≥ 40 mg/dL	≥ 1.04 mmol/L
Homocysteine: Females	0.40–1.89 mg/L	3–14 mcmol/L
Homocysteine: Males	0.54–2.16 mg/L	4–16 mcmol/L
Human chorionic gonadotropin (hCG), quantitative	< 5 mIU/mL	< 5 IU/L
Immunoglobulins: IgA	70–300 mg/dL	0.7–3.0 g/L
Immunoglobulins: IgD	< 8 mg/dL	< 80 mg/L
Immunoglobulins: IgE	0.01–0.04 mg/dL	0.1–0.4 mg/L
Immunoglobulins: IgG	640–1430 mg/dL	6.4–14.3 g/L
Immunoglobulins: IgG1	280–1020 mg/dL	2.8–10.2 g/L
Immunoglobulins: IgG2	60–790 mg/dL	0.6–7.9 g/L
Immunoglobulins: IgG3	14–240 mg/dL	0.14–2.4 g/L
Immunoglobulins: IgG4	11–330 mg/dL	0.11–3.3 g/L
Immunoglobulins: IgM	20–140 mg/dL	0.2–1.4 g/L
Insulin, fasting	2.6–24.9 mcIU/mL	15.6–149.4 pmol/L
Iron: Female	35–145 mcg/dL	6.4–26.5 mcmol/L
Iron: Male	50–150 mcg/dL	9.2–27.5 mcmol/L
Iron-binding capacity, total (TIBC)	250–460 mcg/dL	45–82 mcmol/L
Lactate dehydrogenase (LDH)	60–160 U/L	1–1.67 mckat/L
Lactic acid, venous	6–16 mg/dL	0.67–1.8 mmol/L
Lactose tolerance test	> 15 mg/dL increase in plasma glucose level	> 0.83 mmol/L increase in plasma glucose level
Lead	Pediatric patients: < 20 mcg/dL	Pediatric patients: < 0.97 mcmol/L
Lead	Adult patients: < 80 mcg/dL	Adult patients: < 3.86 mcmol/L
Leukocyte alkaline phosphatase (LAP) score	13–130/100/ polymorphonuclear (PMN) leukocyte neutrophils and bands	—
Lipase	< 95 U/L	< 1.58 mckat/L
Lipoprotein (a) [Lp(a)]	≤ 10 mg/dL	< 13nmol/L
Low-density lipoprotein (LDL-C)	≤ 130 mg/dL	≤ 3.36 mmol/L
Luteinizing hormone (LH), females: Follicular or luteal phase	5–22 mU/mL	5–22 U/L
Luteinizing hormone (LH), females: Midcycle peak	30–250 mU/mL	30–250 U/L
Luteinizing hormone (LH), females: Postmenopausal	> 30 mU/mL	> 30 U/L
Luteinizing hormone (LH), males	3–15 mU/mL	3–15 U/L
Lymphocytes	0.77–4.5 x 103 cells/mcL	0.77–4.5 x 109 cells/L
Magnesium	1.5–2.4 mg/dL	0.62–0.99 mmol/L
Manganese	0.3–0.9 ng/mL	5.5–16.4 nmol/L
Mean corpuscular hemoglobin (MCH)	28–32 pg	—
Mean corpuscular hemoglobin concentration (MCHC)	32–36 g/dL	320–360 g/L
Mean corpuscular volume (MCV)	80–100 fL	—
Metanephrines, fractionated: Metanephrines, free	< 0.50 nmol/L	—
Metanephrines, fractionated: Normetanephrines, free	< 0.90 nmol/L	—
Methemoglobin	< 1.0%	—
Methylmalonic acid (MMA)	≤ 400 nmol/L	47.2 ng/L
Monocytes	0.14–1.3 x 103 cells/mcL	0.14–1.3 x 109 cells/L
Myoglobin: Females	25–58 mcg/L	1.4–3.5 nmol/L
Myoglobin: Males	28–72 mcg/L	1.6–4.1 nmol/L
Norepinephrine, supine	50–440 pg/mL	0.3–2.6 nmol/L
N-Terminal propeptide of BNP (NT-proBNP): ≥ 75 Years	< 450 pg/mL	< 450 ng/L
N-Terminal propeptide of BNP (NT-proBNP): < 75 Years	< 125 pg/mL	< 125 ng/L
Osmolality	275–295 mOsm/kg H2O	275–295 mmol/ kg H2O
Osmotic fragility test	Increased fragility if hemolysis occurs in > 0.5% sodium chloride	—
Osmotic fragility test	Decreased fragility if hemolysis is incomplete in 0.3% sodium chloride	—
Oxygen partial pressure (PO2)	Arterial: 80–100 mm Hg	10.7–13.3 kPa
Parathyroid hormone (PTH)	10–65 pg/mL	10–65 ng/L
Parathyroid hormone–related peptide (PTHrP)	< 2.0 pmol/L	—
Partial thromboplastin time, activated (aPTT)	25–35 seconds	—
pH: Arterial	Arterial: 7.35–7.45	—
pH: Venous	Venous: 7.32–7.43	—
Phosphorus, inorganic	3.0–4.5 mg/dL	0.97–1.45 mmol/L
Plasma in females*	28–43 mL/kg body wt	0.028–0.043 L/kg body wt
Plasma in males*	25–44 mL/kg body wt	0.025–0.044 L/kg body wt
Platelet count	150–350 x 103/mcL	150–350 x 109/L
Platelet life span, using chromium-51 (51Cr)	8–12 days	—
Porphyrins	≤ 1.0 mcg/dL	≤ 10 mcg/L
Potassium	3.5–5 mEq/L	3.5–5 mmol/L
Prealbumin (transthyretin)	18–45 mg/dL	180–450 mg/L
Progesterone: Follicular phase	< 1 ng/mL	< 0.03 nmol/L
Progesterone: Luteal phase	3–30 ng/mL	0.1–0.95 nmol/L
Prolactin: Females (nonpregnant)	< 20 mcg/L	< 870 pmol/L
Prolactin: Males	< 15 mcg/L	< 652 pmol/L
Prostate-specific antigen, ratio of free to total (PSA-F:PSA-T)	> 0.25	—
Prostate-specific antigen, total (PSA-T)	0–4 ng/mL	0–4 mcg/L
Protein C activity	67–131%	—
Protein C resistance, activated ratio (APC-R)	2.2–2.6	—
Protein S activity	82–144%	—
Protein, total	6–7.8 g/dL	60–78 g/L
Prothrombin time (PT)	11–13 seconds	—
Pyruvic acid	0.08–0.16 mmol/L	—
Red blood cell count	4.2–5.9 x 106 cells/mcL	4.2–5.9 x 1012 cells/L
Red blood cell survival rate, using 51Cr	T1/2 = 28 days	—
Red blood cells in females*	20–30 mL/kg body wt	0.02–0.03 L/kg body wt
Red blood cells in males*	25–35 mL/kg body wt	0.025–0.035 L/kg body wt
Reticulocyte count: Absolute	23–90 x 103/mcL	23–90 x 109/L
Reticulocyte count: Percentage	0.5–1.5%	—
Rheumatoid factor (RF), by nephelometry	< 20 IU/mL	< 20 kIU/L
Segmented neutrophils	2.6–8.5 x 103 cells/mcL	2.6–8.5 x 109 cells/L
Sodium	136–145 mEq/L	136–145 mmol/L
Sodium-depleted	2.9–24 ng/mL/hour	2.9–24 mcg/L/hour
Sodium-repleted	0.6 (or lower)–4.3 ng/mL/hour	0.6 (or lower)–4.3 mcg/L/hour
Testosterone (total), adults: Females	20–75 ng/dL	0.7–2.6 nmol/L
Testosterone (total), adults: Males	300–1200 ng/dL	10–42 nmol/L
Thrombin time	18.5–24 seconds	—
Thyroid iodine-123 (123I) uptake	5–30% of administered dose at 24 hour	—
Thyroid-stimulating hormone (TSH)	0.5–5.0 mcIU/mL	0.5–5.0 mIU/L
Thyroxine (T4): Free	0.9–2.4 ng/dL	12–31 pmol/L
Thyroxine (T4): Free index	4–11	—
Thyroxine (T4): Total	5–12 mcg/dL	64–155 nmol/L
Total (CH50)	30–75 U/mL	30–75 kU/L
Total (TC)	150–199 mg/dL	3.88–5.15 mmol/L
Transferrin	200–360 mg/dL	2.0–3.6 g/L
Transferrin saturation	20–50%	—
Triglycerides (fasting)	Normal: < 150 mg/dL	Normal: < 1.69 mmol/L
Triglycerides (fasting)	Borderline: 150–199 mg/dL	Borderline: 1.69–2.25 mmol/L
Triglycerides (fasting)	High: 200–499 mg/dL	High: 2.26–5.64 mmol/L
Triglycerides (fasting)	Very high: ≥ 500 mg/dL	Very high: > 5.65 mmol/L
Triiodothyronine (T3): Total	70–195 ng/dL	1.1–3.0 nmol/L
Triiodothyronine (T3): Uptake	25–35%	—
Troponin I (Contemporary assay)	< 0.04 ng/mL	< 0.04 mcg/L
Troponin I: Females	Females: ≤ 10 ng/L	<1.0 mcg/L
Troponin I: Males	Males: ≤ 15 ng/L	<1.5 mcg/L
Troponin T (Contemporary assay)	≤ 0.03 ng/mL	≤ 0.03 mcg/L
Troponin T, highly sensitive (hs-TnT): Females	≤ 10 ng/L	<1.0 mcg/L
Troponin T, highly sensitive (hs-TnT): Males	≤ 15 ng/L	<1.5 mcg/L
Urea nitrogen (BUN)	8–20 mg/dL	2.9–7.1 mmol/L
Uric acid	2.5–8 mg/dL	0.15–0.47 mmol/L
Vitamin B12	200–800 pg/mL	148–590 pmol/L
Vitamin C (ascorbic acid): Leukocyte	< 20 mg/dL	< 1136 mcmol/L
Vitamin C (ascorbic acid): Total	0.4–1.5 mg/dL	23–85 mcmol/L
Vitamin D: 1,25-Dihydroxycholecalciferol (calcitriol)	25–65 pg/mL	65–169 pmol/L
Vitamin D: 25-Hydroxycholecalciferol	15–80 ng/mL	37–200 nmol/L
White blood cell count	4.5–11 x 103 cells/mcL	4.5–11 x 109 cells/L
Zinc	66–110 mcg/dL	10.1–16.8 mcmol/L

Representative Laboratory Reference Values: Blood, Plasma, and Serum

Normal Values Source 2:

HEMATOLOGY – Red Blood Cells.

It is the measurement of the normal range of red blood cell count of a person.

RBC (Male) 4.2 – 5.6 10^6 / µL [Scientific Notation: 10^6 = 1,000,000]
RBC (Female) 3.8 – 5.1 10^6 / µL
RBC (Child) 3.5 – 5.0 10^6 / µL

HEMATOLOGY – White Blood Cells.

It is the measurement of the white blood cell count in the body.

WBC (Male) 3.8 – 11.0 10^3 / mm3 [Scientific Notation: 10^3 = 1,000]
WBC (Female) 3.8 – 11.0 10^3 / mm3
WBC (Child) 5.0 – 10.0 10^3 / mm3

HEMOGLOBIN

Diseases that affect red blood cells or the amount of hemoglobin in the blood may be

Hgb (Male) 14 – 18 g/dL
Hgb (Female) 11 – 16 g/dL
Hgb (Child) 10 – 14 g/dL
Hgb (Newborn) 15 – 25 g/dL

HEMATOCRIT

Determines the proportion of blood that is made up of red blood cells and may be used to determine the severity of anemia.

Hct (Male) 39 – 54%
Hct (Female) 34 – 47%
Hct (Child) 30 – 42%
MCV 78 – 98 fL
MCH 27 – 35 pg
MCHC 31 – 37%
neutrophils 50 – 81%
bands 1 – 5%
lymphocytes 14 – 44%
monocytes 2 – 6%
eosinophils 1 – 5%
basophils 0 – 1%

CARDIAC MARKERS

Used to diagnose patients with chest discomfort suspected with acute coronary syndrome (ACS).

troponin I 0 – 0.1 ng/ml (onset: 4-6 hrs, peak: 12-24 hrs, return to normal: 4-7 days)
troponin T 0 – 0.2 ng/ml (onset: 3-4 hrs, peak: 10-24 hrs, return to normal: 10-14 days)
myoglobin (Male) 10 – 95 ng/ml (onset: 1-3 hrs, peak: 6-10 hrs, return to normal: 12-24 hrs)
myoglobin (Female) 10 – 65 ng/ml (onset: 1-3 hrs, peak: 6-10 hrs, return to normal: 12-24 hrs)

GENERAL CHEMISTRY

The general chemistry panel evaluates a number of the body’s components.

acetone 0.3 – 2.0 mg%
albumin 3.5 – 5.0 gm/dL
alkaline phosphatase 32 – 110 U/L
anion gap 5 – 16 mEq/L
ammonia 11 – 35 µmol/L
amylase 50 – 150 U/dL
AST,SGOT (Male) 7 – 21 U/L
AST,SGOT (Female) 6 – 18 U/L
bilirubin, direct 0.0 – 0.4 mg/dL
bilirubin, indirect total minus direct
bilirubin, total 0.2 – 1.4 mg/dL
BUN 6 – 23 mg/dL
calcium (total) 8 – 11 mg/dL
carbon dioxide 21 – 34 mEq/L
carbon monoxide symptoms at greater than or equal to 10% saturation
chloride 96 – 112 mEq/L
creatine (Male) 0.2 – 0.6 mg/dL
creatine (Female) 0.6 – 1.0 mg/dL
creatinine 0.6 – 1.5 mg/dL
ethanol 0 mg%; Coma:
greater than or equal to 400 – 500 mg%
folic acid 2.0 – 21 ng/mL
glucose 65 – 99 mg/dL
(diuresis greater than or equal to 180 mg/dL)
HDL (Male) 25 – 65 mg/dL
HDL (Female) 38 – 94 mg/dL
iron 52 – 169 µg/dL
iron binding capacity 246 – 455 µg/dL
lactic acid 0.4 – 2.3 mEq/L
lactate 0.3 – 2.3 mEq/L
lipase 10 – 140 U/L
magnesium 1.5 – 2.5 mg/dL
osmolarity 276 – 295 mOsm/kg
parathyroid hormone 12 – 68 pg/mL
phosphorus 2.2 – 4.8 mg/dL
potassium 3.5 – 5.5 mEq/L
SGPT 8 – 32 U/L
sodium 135 – 148 mEq/L
T3 0.8 – 1.1 µg/dL
thyroglobulin less than 55 ng/mL
thyroxine (T4) (total) 5 – 13 µg/dL
total protein 5 – 9 gm/dL
TSH Less than 9 µU/mL
urea nitrogen 8 – 25 mg/dL
uric acid (Male) 3.5 – 7.7 mg/dL
uric acid (Female) 2.5 – 6.6 mg/dL
LIPID PANEL (Adult)
cholesterol (total) Less than 200 mg/dL desirable
cholesterol (HDL) 30 – 75 mg/dL
cholesterol (LDL) Less than 130 mg/dL desirable
triglycerides (Male) Greater than 40 – 170 mg/dL
triglycerides (Female) Greater than 35 – 135 mg/dL

URINE

Urine tests are used to diagnose different metabolic and kidney disorders.

color Straw
specific gravity 1.003 – 1.040
pH 4.6 – 8.0
Na 10 – 40 mEq/L
K Less than 8 mEq/L
C1 Less than 8 mEq/L
protein 1 – 15 mg/dL
osmolality 80 – 1300 mOsm/L
24 HOUR URINE
amylase 250 – 1100 IU / 24 hr
calcium 100 – 250 mg / 24 hr
chloride 110 – 250 mEq / 24 hr
creatinine 1 – 2 g / 24 hr
creatine clearance (Male) 100 – 140 mL / min
creatine clearance (Male) 16 – 26 mg / kg / 24 hr
creatine clearance (Female) 80 – 130 mL / min
creatine clearance (Female) 10 – 20 mg / kg / 24 hr
magnesium 6 – 9 mEq / 24 hr
osmolality 450 – 900 mOsm / kg
phosphorus 0.9 – 1.3 g / 24 hr
potassium 35 – 85 mEq / 24 hr
protein 0 – 150 mg / 24 hr
sodium 30 – 280 mEq / 24 hr
urea nitrogen 10 – 22 gm / 24 hr
uric acid 240 – 755 mg / 24 hr

COAGULATION

Coagulation factor tests calculate the role of proteins necessary for blood clot formation.

ACT 90 – 130 seconds
APTT 21 – 35 seconds
platelets 140,000 – 450,000 /ml
plasminogen 62 – 130%
PT 10 – 14 seconds
PTT 32 – 45 seconds
FSP Less than 10 µg/dL
fibrinogen 160 – 450 mg/dL
bleeding time 3 – 7 minutes
thrombin time 11 – 15 seconds

CEREBRAL SPINAL FLUID

It is a series of tests that assess substances present in the cerebral spinal fluid in order to be able to diagnose circumstances affecting the central nervous system.

appearance clear
glucose 40 – 85 mg/dL
osmolality 290 – 298 mOsm/L
pressure 70 – 180 mm/H2O
protein 15 – 45 mg/dL
total cell count 0 – 5 cells
WBCs 0 – 6 / µL

HEMODYNAMIC PARAMETERS

The examination of hemodynamic parameters over time, such as blood pressure and heart rate in order to gauge blood flow and circulation.

cardiac index 2.5 – 4.2 L / min / m2
cardiac output 4 – 8 LPM
left ventricular stroke work index 40 – 70 g / m2 / beat
right ventricular stroke work index 7 – 12 g / m2 / beat
mean arterial pressure 70 – 105 mm Hg
pulmonary vascular resistance 155 – 255 dynes / sec / cm to the negative 5
pulmonary vascular resistance index 255 – 285 dynes / sec / cm to the negative 5
stroke volume 60 – 100 mL / beat
stroke volume index 40 – 85 mL / m2 / beat
systemic vascular resistance 900 – 1600 dynes / sec / cm to the negative 5
systemic vascular resistance index 1970 – 2390 dynes / sec / cm to the negative 5
systolic arterial pressure 90 – 140 mm Hg
diastolic arterial pressure 60 – 90 mm Hg
central venous pressure 2 – 6 mm Hg; 2.5 – 12 cm H2O
ejection fraction 60 – 75%
left arterial pressure 4 – 12 mm Hg
right atrial pressure 4 – 6 mm Hg
pulmonary artery systolic 15 – 30 mm Hg
pulmonary artery diastolic 5 – 15 mm Hg
pulmonary artery pressure 10 – 20 mm Hg
pulmonary artery wedge pressure 4 – 12 mm Hg
pulmonary artery end diastolic pressure 8 – 10 mm Hg
right ventricular end diastolic pressure 0 – 8 mm Hg

NEUROLOGICAL VALUES

Confirms or excludes the occurrence of a neurological disorder

cerebral perfusion pressure 70 – 90 mm Hg
intracranial pressure 5 – 15 mm Hg or 5 – 10 cm H2O

Tests performed in order to measure the pH and the amount of oxygen (O2) and carbon dioxide (CO2) present in a sample of blood. The results of the tests are used to evaluate lung function and aid to identify an acid-base imbalance. The sample may be taken from arterial or venous blood.